Ascendis Pharma A/S (ASND)

NASDAQ: ASND · Real-Time Price · USD

166.64

-3.80 (-2.23%)

At close: May 01, 2025, 3:59 PM

168.13

0.89%

Pre-market: May 02, 2025, 07:56 AM EDT

Ascendis Pharma A/S Balance Sheet Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	559.54M	392.16M	444.77M	446.27M	584.52M	598.11M	277.86M	195.35M	180.33M
Short-Term Investments	n/a	7.28M	290.69M	235.8M	134.28M	n/a	n/a	n/a	n/a
Long-Term Investments	13.57M	5.69M	30.42M	145.91M	124.46M	15.54M	17.08M	n/a	n/a
Other Long-Term Assets	2.32M	2.13M	1.92M	1.81M	1.38M	1.46M	1.16M	293K	268K
Receivables	177.44M	55.77M	11.91M	2.2M	387K	804K	2.63M	2.38M	287K
Inventory	295.61M	208.93M	130.67M	75.41M	1.00	-3	1.00	1.00	1.00
Other Current Assets	n/a	n/a	13.72M	20.99M	n/a	n/a	n/a	n/a	n/a
Total Current Assets	1.06B	702.72M	923.47M	805.89M	740.13M	611.17M	292.91M	204.63M	183.96M
Property-Plant & Equipment	98.71M	110.63M	129.09M	126.05M	108.11M	45.07M	4.33M	2.56M	2.35M
Goodwill & Intangibles	4.03M	4.42M	4.83M	5.27M	5.72M	3.5M	3.5M	3.5M	3.5M
Total Long-Term Assets	118.63M	122.87M	166.27M	279.04M	239.66M	65.56M	26.06M	6.34M	6.11M
Total Assets	1.18B	825.59M	1.09B	1.08B	979.79M	676.73M	318.97M	210.98M	190.07M
Account Payables	96.39M	94.57M	101.03M	59.42M	21.9M	27.77M	19.74M	17.43M	13.08M
Deferred Revenue	936K	1.18M	n/a	2.6M	363K	858K	6.9M	n/a	94K
Short-Term Debt	491.54M	11.23M	11.63M	7M	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	317.77M	32.72M	12.83M	-3M	664K	977K	6.91M	6.33M	380K
Total Current Liabilities	907.86M	197.34M	171.27M	100.36M	52.8M	47.99M	38.92M	23.77M	13.46M
Long-Term Debt	365.08M	534.25M	387.56M	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	155.07M	172.16M	2.96M	3.16M	908K	n/a	n/a	n/a
Total Long-Term Liabilities	377.34M	773.94M	655.12M	100.93M	88.28M	31.63M	26.64M	23.77M	13.17M
Total Liabilities	1.29B	971.28M	826.39M	201.29M	141.08M	79.62M	38.92M	23.77M	13.46M
Total Debt	856.62M	644.26M	508.38M	104.96M	91.97M	36.62M	n/a	n/a	n/a
Common Stock	8.15M	7.75M	7.67M	7.65M	7.22M	6.44M	5.66M	4.97M	4.35M
Retained Earnings	n/a	-2.28B	-1.86B	-1.41B	-1.03B	-611.32M	-393.31M	-263.21M	159.25M
Comprehensive Income	n/a	-153.45M	255.67M	875.99M	831.49M	590.67M	274.39M	182.24M	13.01M
Shareholders Equity	-105.71M	-145.7M	263.35M	883.63M	838.71M	597.11M	280.05M	187.21M	176.61M
Total Investments	13.57M	12.96M	321.11M	381.7M	258.73M	15.54M	17.08M	n/a	n/a